Skip to content

Periodontal Granulation Tissue Preservation in Surgical Periodontitis Treatment

Periodontal Granulation Tissue Preservation in Surgical Periodontal Disease Treatment. A Randomized Clinical Trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05533528
Enrollment
25
Registered
2022-09-09
Start date
2022-05-03
Completion date
2027-02-01
Last updated
2026-02-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Periodontal Pocket, Periodontal Diseases, Periodontal Bone Loss

Brief summary

The objective of this study will be to evaluate a new protocol for the surgical treatment of periodontal disease with two novelties: to make a single incision in the midline of the interproximal area to respect the vascular supply and preserve the granulation tissue with regenerative potential. The investigators will carry out a controlled and randomized clinical trial with a control group (n=25; modified Kirkland flap) and a test group (n=25; experimental surgical protocol: incision in the mid-interproximal area of the papilla and preservation of the granulation tissue). Clinical parameters will be taken at the time of surgery and 12 months follow-up: bleeding on probing (BoP), clinical attachment level (CAL), residual probing depth (rPD),Probing pocket depth reduction (PPDr), recession (REC), interproximal gingival recession (iGR), width of keratinized gingiva (KT), gain of supra-alveolar clinical attachment (SUPRA-AG), early wound healing index (EHI).

Interventions

A sulcular incision will be made in the affected teeth, followed by an incision from the buccal aspect in the mid-portion of the interproximal tissues The buccal and lingual flaps will be elevated. For periodontal granulation tissue preservation group, the soft tissues covering the alveolar crest will be prepared. A third incision will separate the pocket epithelium from the soft tissue (granulation tissue) attached to the bone. The pocket epithelium will be removed. The root surfaces will be carefully scaled and planed in both groups. Ethylenediaminetetraacetic acid (24%) will be applied to the root surfaces and removed after 2 minutes with abundant saline solution. In the experimental group, the preserved attached soft tissue and the space between it and the root surface will be irrigated with 10% polyvinylpyrrolidone-iodine. Finally, the flaps will be positioned and sutured.

Sponsors

Universidad de Murcia
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Stage III or IV periodontitis, including all grades. * Unresolved deep pockets (probing pocket depth \[PPD\] \>5 mm + BoP) 4 to 6 weeks after non-surgical treatment. * Interproximal plaque index \<35% maintained during periodontal treatment and maintenance. * Adherence to periodontal maintenance appointments.

Exclusion criteria

* Systemic disease contraindicating periodontal surgery. * Teeth with incorrect endodontic treatment or restoration. * Stage I or II periodontitis.

Design outcomes

Primary

MeasureTime frameDescription
Clinical attachment gain (CAG)12 monthsClinical attachment gain

Secondary

MeasureTime frameDescription
PPDr12 monthsProbing pocket depth reduction
iGR12 monthsinterproximal gingival recession
Early Healing Index (EHI)1 weekFive types of early healing will be recorded: EHI 1, complete closure of the incision line, with no fibrin; EHI 2-3, formation of a thin line or a fibrin clot in the incision area, respectively; EHI 4-5, incomplete closure with partial necrosis or necrosis of the incision area, respectively.
SUPRA-AG12 monthsSupra-alveolar attachment gain
rPD12 monthsresidual probing depth

Countries

Spain

Contacts

CONTACTAntonio J Ortiz-Ruiz, MD
ajortiz@um.es+34 868888581
CONTACTJosé A Moreno-Rodríguez, DDS
joseantonio171087@hotmail.com+34 620538483

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 20, 2026